DBV TECHNOLOGIES Aktie
| 3,53EUR | 0,06EUR | 1,73% |
WKN DE: A1JWB7 / ISIN: FR0010417345
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 92 | 85 | 104 | 109 | 125 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 101 | 209 | 144 | 43 | 181 |
| Summe Anlagevermögen | 28 | 22 | 22 | 21 | 18 |
| Summe Aktiva | 129 | 231 | 166 | 63 | 199 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 42 | 49 | 39 | 37 | 55 |
| Summe Eigenkapital | 87 | 182 | 127 | 26 | 144 |
| Summe Passiva | 129 | 231 | 166 | 63 | 199 |
Adresse
| 107 avenue de la Republique, 92320 Chatillon | |
| Telefon | +33 (1) 55-42-78-78 |
| Fax | +33 (1) 43-26-10-83 |
| Internet | http://www.dbv-technologies.com |
Management
|
Adora Ndu
Independent Director |
|
Daniel Tassé
Chief Executive Officer & Director |
|
Danièle Guyot-Caparros
Independent Director |
|
James Briggs
Chief Human Resources Officer |
|
Julie O'Neill
Independent Director |
|
Katie Matthews
Investor Relations Contact |
|
Kevin P. Malobisky
Chief Operations Officer |
|
Kevin Trapp
Chief Commercial Officer |
|
Maïlys Ferrère
Director |
|
Michael J. Goller
Director |
|
Michel de Rosen
Chairman |
|
Michele F. Robertson
Chief Legal Officer |
|
Pascal Wotling
Chief External Manufacturing Officer |
|
Pascale Ehouarn
Senior VP-Manufacturing Sciences & Technology |
|
Pharis Mohideen
Chief Medical Officer |
|
Philina Lee
Independent Director |
|
Ravi Madduri Rao
Independent Director |
|
Robert G. Pietrusko
Chief Regulatory Officer |
|
Timothy E. Morris
Independent Director |
|
Virginie Simone Jeanine Verrechia
Chief Financial & Accounting Officer |